Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caelyx Cardiac Effects in Elderly Breast Cancer
NCT00284336Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Jan 2006
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in breast cancer, sponsored by UZ Leuven. Started Jan 2006; status: completed.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00284336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00284336.